Head-to-head comparison of cardiac troponin T and troponin I in patients without acute coronary syndrome: a systematic review

Biomarkers

Volumn 22, Issue 8, 2017, Pages 701-708

  Árnadóttir, Ásthildur ^a   Falk Klein, Christine ^a   Iversen, Kasper ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

mortality; non acute coronary syndrome elevation; non cardiac elevation; prevalence; systematic review; Troponin

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; HEART; HUMAN; MORBIDITY; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW; ACUTE CORONARY SYNDROME; CARDIAC MUSCLE; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; BIOMARKERS; KIDNEY FAILURE, CHRONIC; MYOCARDIUM; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 85033224620     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/1354750X.2017.1335779     Document Type: Review

References (61)

1. Abaci, A., et al., 2004. Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value. Clinical cardiology, 27 (12), 704–709.
2. Ahmed, A.N., et al., 2014. Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis. Annals of medicine, 46 (8), 653–663.
3. Apple, F.S., and Collinson, P.O., 2012. Analytical characteristics of high-sensitivity cardiac troponin assays. Clinical chemistry, 58 (1), 54–61.
4. Apple, F.S., et al., 2002. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation, 106 (23), 2941–2945.
5. Artunc, F., et al., 2012. Sensitive troponins–which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One, 7 (10), e47610.
6. Bargnoux, A.S., et al., 2016. Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T? Clinical chemistry and laboratory medicine, 54 (4), 673–682.
7. Bertinchant, J.P., et al., 1996. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clinical biochemistry, 29 (6), 587–594.
8. Bjurman, C., et al., 2015. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. Clinical biochemistry, 48 (4–5), 302–307.
9. Blankenberg, S., et al., 2016. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. European heart journal, 37 (30), 2428–2437.
10. Brunet, P., et al., 2008. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome. International journal of cardiology, 129 (2), 205–209.
11. Buiten, M.S., et al., 2015. Serum cardiac Troponin-I is superior to Troponin-T as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease. PLoS One, 10 (8), e0134245.
12. Cardinaels, E.P., et al., 2013. Time-dependent degradation pattern of cardiac troponin T following myocardial infarction. Clinical chemistry, 59 (7), 1083–1090.
13. Cardinaels, E.P., et al., 2015. Clinical interpretation of elevated concentrations of cardiac Troponin T, but not Troponin I, in nursing home residents. American medical directors association, 16 (10), 884–891.
14. Cox, F.M., et al., 2010. The heart in sporadic inclusion body myositis: a study in 51 patients. Journal of neurology, 257 (3), 447–451.
15. de Antonio, M., et al., 2013. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification. Clinica chimica acta, 426, 18–24.
16. deFilippi, C., et al., 2012. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clinical chemistry, 58 (9), 1342–1351.
17. di Stefano, S., et al., 2007. Plasma troponins as markers of myocardial damage during cardiac surgery with extracorporeal circulation. The Tohoku journal of experimental medicine, 213 (1), 63–69.
18. Diris, J.H., et al., 2004. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation, 109 (1), 23–25.
19. Eggers, K.M., et al., 2011. High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension. Clinica chimica acta, 412 (17–18), 1582–1588.
20. Giannitsis, E., and Katus, H.A., 2013. Cardiac troponin level elevations not related to acute coronary syndromes. Nature reviews cardiology, 10 (11), 623–634.
21. Goodacre, S., et al., 2013. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health technology assessment, 17 (1), v188.
22. Grodin, J.L., et al., 2015. Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. American journal of medicine, 128 (3), 276–282.
23. Guclu, T., et al., 2016. Relationship between high sensitivity troponins and estimated glomerular filtration rate. Clinical biochemistry, 49 (6), 467–471.
24. Hamm, C.W., et al., 2011. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European heart journal, 32, 2999–3054.
25. Hickman, P.E., et al., 2015. Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of long-term mortality in patients with chronic renal failure who underwent dialysis. American journal of cardiology, 115 (11), 1601–1606.
26. Hijazi, Z., et al., 2015. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clinical chemistry, 61 (2), 368–378.
27. Ilva, T., et al., 2008. Clinical significance of cardiac troponins I and T in acute heart failure. European journal of heart failure, 10 (8), 772–779.
28. Jaeger, C., et al., 2016. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. American heart journal, 171 (1), 92–102.
29. Jaffe, A.S., et al., 2011. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. Journal of the American college of cardiology, 58 (17), 1819–1824.
30. Jauch, E.C., et al., 2013. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44 (3), 870–947.
31. Javed, U., et al., 2009. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. The American journal of cardiology, 104 (1), 9–13.
32. Katus, H.A., et al., 1991. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. American journal of cardiology, 67 (16), 1360–1367.
33. Kimenai, D.M., et al., 2016. Direct comparison of clinical decision limits for cardiac troponin T and I. Heart (British Cardiac Society), 102 (8), 610–616.
34. Kocak, E.F., et al., 2015. High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery. Cardiovascular journal of Africa, 26 (6), 234–241.
35. Labugger, R., et al., 2000. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation, 102 (11), 1221–1226.
36. Lee, G.R., et al., 2014. Peri-operative troponin monitoring using a prototype high-sensitivity cardiac troponin I (hs-cTnI) assay: comparisons with hs-cTnT and contemporary cTnI assays. Annals of clinical biochemistry, 51 (Pt 2), 258–268.
37. Lindahl, B., et al., 2013. Evaluation of four sensitive troponin assays for risk assessment in acute coronary syndromes using a new clinically oriented approach for comparison of assays. Clinical chemistry and laboratory medicine, 51 (9), 1859–1864.
38. McEvoy, J.W., et al., 2016. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure and death. JAMA cardiology, 1 (5), 519–528.
39. Michos, E.D., et al., 2014. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Annals of internal medicine, 161 (7), 491–501.
40. Moher, D., et al., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of clinical epidemiology, 62 (10), 1006–1012.
41. Olson, F., et al., 2016. Association between high-sensitive troponin I and coronary artery calcification in a Danish general population. Atherosclerosis, 245, 88–93.
42. Omland, T., et al., 2013. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. Journal of the American college of cardiology, 61 (12), 1240–1249.
43. Ooi, D.S., Isotalo, P.A., and Veinot, J.P., 2000. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clinical chemistry, 46 (3), 338–344.
44. Peivandi, A.A., et al., 2004. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz, 29 (7), 658–664.
45. Pickering, J.W., et al., 2016. Assessment of the European Society of Cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction. Circulation, 134 (20), 1532–1541.
46. Reichlin, T., et al., 2012. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Archives of internal medicine, 172 (16), 1211–1218.
47. Reichlin, T., et al., 2015. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMAJ: Canadian medical association journal = Journal De L'association Medicale Canadienne, 187 (8), E243–E252.
48. Reichlin, T., et al., 2016. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation. Journal of interventional cardiac electrophysiology, 47 (1), 69–74.
49. Rittoo, D., et al., 2014. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. Journal of the American college of cardiology, 63 (22), 2411–2420.
50. Roffi, M., et al., 2016. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Giornale Italiano Di Cardiologia (Rome), 17 (10), 831–872.
51. Rubini, G.M., et al., 2014. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. European heart journal, 35 (34), 2303–2311.
52. Sandoval, Y., et al., 2016. Prognostic value of serial changes in high-sensitivity cardiac Troponin I and T over 3 months using reference change values in hemodialysis patients. Clinical chemistry, 62 (4), 631–638.
53. Sheyin, O., et al., 2015. The prognostic significance of troponin elevation in patients with sepsis: a meta-analysis. Heart lung, 44 (1), 75–81.
54. Sou, S.M., et al., 2016. Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia. Clinical biochemistry, 49 (6), 421–432.
55. Tettamanti, C., et al., 2016. Elevation of NT-proBNP and cardiac troponins in sepsis-related deaths: a forensic perspective. International journal of legal medicine, 130 (4), 1035–1043.
56. Thygesen, K., et al., 2012. Third universal definition of myocardial infarction. European heart journal, 33 (20), 2551–2567.
57. ver Elst, K.M., et al., 2000. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clinical chemistry, 46 (5), 650–657.
58. Vestergaard, K.R., et al., 2016. Prevalence and significance of troponin elevations in patients without acute coronary disease. International journal of cardiology, 222, 819–825.
59. Westwood, M., et al., 2015. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health technology assessment, 19 (44), 1–234.
60. Wu, A.H., et al., 1998. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clinical biochemistry, 44 (6 Pt 1), 1198–1208.
61. Ziebig, R., et al., 2003. Renal elimination of troponin T and troponin I. Clinical chemistry, 49 (7), 1191–1193.